I-Mab (IMAB) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free IMAB Stock Alerts $1.80 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOmega Therapeutics CFO Joshua Reed to departmsn.com - April 16 at 5:33 PMI-Mab (NASDAQ:IMAB) Short Interest Updatemarketbeat.com - April 16 at 8:32 AMI-Mab (NASDAQ:IMAB) Earns "Buy" Rating from Needham & Company LLCamericanbankingnews.com - April 14 at 5:14 AMI-MAB Buy Rating Justified by Strong Leadership and Promising Pipelinemarkets.businessinsider.com - April 12 at 6:29 PMNeedham & Company LLC Reaffirms Buy Rating for I-Mab (NASDAQ:IMAB)marketbeat.com - April 12 at 8:24 AMI-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conferenceprnewswire.com - April 5 at 7:00 AMI-Mab completes divestiture of its Shanghai unit for $80 millioninvesting.com - April 4 at 10:45 AMI-Mab Announces Closing of the Divestiture of Business Operations in Chinauk.finance.yahoo.com - April 2 at 4:09 PMI-Mab Announces Closing of the Divestiture of Business Operations in Chinaprnewswire.com - April 2 at 4:01 PMI-Mab Expected to Post FY2025 Earnings of ($1.75) Per Share (NASDAQ:IMAB)marketbeat.com - March 20 at 6:55 AMHC Wainwright Reaffirms Buy Rating for I-Mab (NASDAQ:IMAB)marketbeat.com - March 18 at 5:32 PMI-Mab Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - March 18 at 8:40 AMI-Mab Reports Full Year 2023 Financial Results and Business Updatefinance.yahoo.com - March 14 at 8:33 PMI-MAB Stock (NASDAQ:IMAB), Short Interest Reportbenzinga.com - February 22 at 12:00 PMI-Mab: Trading Below Net Cash With Multiple Upside Optionsseekingalpha.com - February 18 at 10:40 AMI-Mab to Divest Chinese Unit for Up to $80Mmarketwatch.com - February 7 at 1:20 PMI-Mab to divest Chinese assets amid rising geopolitical tensionsmsn.com - February 7 at 1:20 PMI-Mab Signs Agreement to Divest its Assets and Business Operations in Chinafinance.yahoo.com - February 7 at 8:19 AMI-Mab (NASDAQ:IMAB) Sees Significant Decline in Short Interestmarketbeat.com - January 31 at 2:12 AMAsian Equities Traded in the US as American Depositary Receipts Advance in Thursday Tradingmsn.com - January 11 at 2:20 PMI-Mab (IMAB) interactive stock chart – Yahoo Financeuk.finance.yahoo.com - December 31 at 6:49 PMI-MAB Stock (NASDAQ:IMAB) Dividends: History, Yield and Datesbenzinga.com - December 28 at 9:32 AMI-Mab Expected to Earn FY2023 Earnings of ($1.85) Per Share (NASDAQ:IMAB)marketbeat.com - December 21 at 7:46 AMI-Mab (NASDAQ:IMAB) Given Overweight Rating at Cantor Fitzgeraldmarketbeat.com - December 21 at 7:36 AMIndividual investors account for 41% of I-Mab's (NASDAQ:IMAB) ownership, while private equity firms account for 26%finance.yahoo.com - November 19 at 12:36 PMI-Mab Announces Participation at Jefferies and Piper Conferences in Novemberfinance.yahoo.com - November 6 at 9:30 AMI-Mab gains FDA breakthrough tag for kidney disease therapymsn.com - November 2 at 7:17 PMI-Mab:Felzartamab Granted Breakthrough Therapy Designation By FDA For Primary Membranous Nephropathymarkets.businessinsider.com - November 2 at 2:17 PMFelzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)finance.yahoo.com - November 2 at 9:17 AMI-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023finance.yahoo.com - November 1 at 12:41 PMI-Mab Announces Phase 1 Data of Givastomig at ESMO 2023finance.yahoo.com - October 16 at 8:17 AMI-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1BB Bispecific Antibody TJ-L14B/ABL503finance.yahoo.com - October 10 at 10:04 AMRay Dalio on Potential US China War and Rise of Chinainsidermonkey.com - October 5 at 6:16 PMExpert Ratings for I-MABmarkets.businessinsider.com - September 25 at 6:19 PMNeedham Maintains I-Mab - ADR (IMAB) Buy Recommendationnasdaq.com - September 25 at 1:19 PMUPDATE 1-AbbVie terminates deal with I-Mab to develop cancer drugfinance.yahoo.com - September 22 at 7:16 PMI-Mab: Why This Company Trades At A Third The Value Of Its Cashmsn.com - September 13 at 6:14 PMWhere I-MAB Stands With Analystsmarkets.businessinsider.com - September 5 at 4:24 PMI-Mab (IMAB) stock historical prices & data – Yahoo Financeuk.finance.yahoo.com - September 3 at 8:02 AMShort Interest in I-Mab (NASDAQ:IMAB) Rises By 7.9%marketbeat.com - September 1 at 2:56 PMBarclays PLC Boosts Stock Holdings in I-Mab (NASDAQ:IMAB)marketbeat.com - August 20 at 4:10 AMCantor Fitzgerald Reiterates I-Mab - ADR (IMAB) Overweight Recommendationmsn.com - August 19 at 4:46 AMAnalyst Ratings for I-MABmarkets.businessinsider.com - August 18 at 6:45 PMI-Mab (NASDAQ:IMAB) Q2 2023 Earnings Call Transcriptinsidermonkey.com - August 18 at 12:01 PMI-Mab (NASDAQ:IMAB) Stock Rating Reaffirmed by Cantor Fitzgeraldmarketbeat.com - August 18 at 11:13 AMI-Mab Biopharma Non-GAAP EPADS of -$1.05 misses by $0.26, revenue of $2.7M misses by $0.3Mseekingalpha.com - August 17 at 9:44 AMI-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updatesfinance.yahoo.com - August 17 at 9:44 AMI-Mab Biopharma 1H 2023 Earnings Previewseekingalpha.com - August 16 at 11:43 PMI-Mab (IMAB) Scheduled to Post Earnings on Thursdaymarketbeat.com - August 10 at 1:53 AMI-Mab to Report Mid-Year 2023 Financial Results, Business and Corporate Updates on August 17, 2023finance.yahoo.com - August 8 at 11:07 AM Get I-Mab News Delivered to You Automatically Sign up to receive the latest news and ratings for IMAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction … Stop right now and do these 3 things to protect yourself IMAB Media Mentions By Week IMAB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMAB News Sentiment▼0.000.44▲Average Medical News Sentiment IMAB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMAB Articles This Week▼01▲IMAB Articles Average Week Get I-Mab News Delivered to You Automatically Sign up to receive the latest news and ratings for IMAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Spyre Therapeutics News Syros Pharmaceuticals News GlycoMimetics News Relmada Therapeutics News Amylyx Pharmaceuticals News CervoMed News Rezolute News Incannex Healthcare News Sagimet Biosciences News FibroGen News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMAB) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding I-Mab Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
